SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that new data from a phase 3 trial of the multi-center, randomized ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...

Women’s HRT patches control prostate cancer as well as standard hormone injections, but with fewer hot flushes and less bone ...

Add Yahoo as a preferred source to see more of our stories on Google. International experts have recommended quick and targeted MRI scans for prostate cancer screening. Some 21 urologists, ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

Not all patients will want to take triplet therapy, but those with high-volume prostate cancer who are chemotherapy eligible are usually a good fit, explained Neal D. Shore, MD, FACS. For patients ...

Thousands of men with advanced prostate cancer in England are set to benefit from a life-extending drug that can be taken at home after it was given the go-ahead for NHS use. Talazoparib, also known ...

Rishi Sunak has urged men to be checked for prostate cancer as part of a new screening drive. The former prime minister has ...